Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
出版年份 2023 全文链接
标题
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
作者
关键词
-
出版物
MELANOMA RESEARCH
Volume 33, Issue 6, Pages 462-474
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-10-04
DOI
10.1097/cmr.0000000000000926
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acetylation-dependent regulation of BRAF oncogenic function
- (2022) Xiangpeng Dai et al. Cell Reports
- Resistance Mechanisms to Anti-PD Cancer Immunotherapy
- (2022) Matthew D. Vesely et al. Annual Review of Immunology
- Epigenetics Regulates Antitumor Immunity in Melanoma
- (2022) Yuhan Chen et al. Frontiers in Immunology
- Pathology of Immunotherapy-induced Responses in Cutaneous Melanoma: Current Evidences and Future Perspectives
- (2022) Alice Indini et al. ADVANCES IN ANATOMIC PATHOLOGY
- Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach
- (2021) Kevin B. Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Epigenetic Regulation in Melanoma: Facts and Hopes
- (2021) Emilio Francesco Giunta et al. Cells
- KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
- (2021) Shang-Min Zhang et al. NATURE
- Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma
- (2021) Chun Yang et al. Cancers
- miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
- (2021) Mai-Huong Thi Nguyen et al. Biomolecules
- The miRNAs Role in Melanoma and in Its Resistance to Therapy
- (2020) Francesca Varrone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
- (2020) Jing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Gain-of-function genetic alterations of G9a drive oncogenesis
- (2020) Shinichiro Kato et al. Cancer Discovery
- Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
- (2020) Minjeong Yeon et al. Frontiers in Cell and Developmental Biology
- MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
- (2019) Ophélia Maertens et al. Cancer Discovery
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target
- (2019) Elias Orouji et al. INTERNATIONAL JOURNAL OF CANCER
- miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
- (2019) Simona Caporali et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial
- (2019) Anna Maria Di Giacomo et al. CLINICAL CANCER RESEARCH
- miR‐140‐5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β‐catenin and NF‐κB cascades
- (2019) Ge Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
- (2019) Corrado Caslini et al. ONCOGENE
- SOX4: The unappreciated oncogene
- (2019) Carlos S. Moreno SEMINARS IN CANCER BIOLOGY
- 1370PPhase Ib/II study (SENSITIZE) assessing safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical outcome of domatinostat in combination with pembrolizumab in patients with advanced melanoma refractory/non-responding to prior checkpoint inhibitor therapy
- (2019) J C Hassel et al. ANNALS OF ONCOLOGY
- Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis
- (2019) Wenkang Luan et al. Cell Death & Disease
- Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
- (2019) Anne Catherine Bretz et al. Journal for ImmunoTherapy of Cancer
- Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
- (2019) Francesco Mannavola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation
- (2018) Daniel Zingg et al. CANCER CELL
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Long non-coding RNAs in melanoma
- (2018) Xin Yu et al. CELL PROLIFERATION
- Anti-miRNA oligonucleotides: A comprehensive guide for design
- (2018) Joana Filipa Lima et al. RNA Biology
- Epigenetic regulators of programmed death-ligand 1 expression in human cancers
- (2018) Sachin Kumar et al. Translational Research
- Tackling malignant melanoma epigenetically: histone lysine methylation
- (2018) Elias Orouji et al. Clinical Epigenetics
- DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients
- (2017) Mario Venza et al. HUMAN PATHOLOGY
- Epigenetics of malignant melanoma
- (2017) Bruce Moran et al. SEMINARS IN CANCER BIOLOGY
- Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
- (2017) Yousef Zakharia et al. Oncotarget
- Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
- (2017) Petko Fiziev et al. Cell Reports
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- (2017) Goran Micevic et al. Clinical Epigenetics
- Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK
- (2017) Luca Hegedüs et al. Frontiers in Oncology
- MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
- (2017) Jacinta L. Simmons et al. Scientific Reports
- Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic
- (2017) Samer Bayda et al. CURRENT MEDICINAL CHEMISTRY
- Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance
- (2016) A. Krumm et al. CANCER RESEARCH
- Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside
- (2016) Eva Hornig et al. EXPERIMENTAL DERMATOLOGY
- TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells
- (2016) Wei Deng et al. IUBMB LIFE
- Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics
- (2016) Nikhil Tyagi et al. Journal of Biomedical Nanotechnology
- Melanoma addiction to the long non-coding RNA SAMMSON
- (2016) Eleonora Leucci et al. NATURE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
- (2016) Nageatte Ibrahim et al. Cancer Medicine
- Panobinostat in multiple myeloma
- (2016) Morie A Gertz Lancet Haematology
- Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer
- (2016) Yuanhui Jia et al. Cell Discovery
- BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1
- (2015) Zhi-Xin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer
- (2015) Ling Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Epigenetic regulation in human melanoma: past and future
- (2015) Debina Sarkar et al. Epigenetics
- Let-7b overexpression leads to increased radiosensitivity of uveal melanoma cells
- (2015) Yixiong Zhou et al. MELANOMA RESEARCH
- Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma
- (2015) Deepanwita Sengupta et al. MOLECULAR & CELLULAR PROTEOMICS
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
- (2015) G M De Donatis et al. ONCOGENE
- Circulating epigenetic biomarkers in melanoma
- (2015) Yu Xin et al. TUMOR BIOLOGY
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients
- (2015) Shigeshi Ono et al. Oncotarget
- Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma
- (2015) Phil F Cheng et al. GENOME BIOLOGY
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- SWI/SNF Chromatin Remodeling Enzymes in Melanocyte Differentiation and Melanoma
- (2014) A. Mehrotra et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma
- (2014) Rainer Tuominen et al. INTERNATIONAL JOURNAL OF CANCER
- DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
- (2014) D. M. Marzese et al. NEURO-ONCOLOGY
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study
- (2013) Eyal Greenberg et al. BIOMARKERS
- Long Non-Coding RNA in Cancer
- (2013) Nina Hauptman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Methylated Tissue Factor Pathway Inhibitor 2 (TFPI2) DNA in Serum Is a Biomarker of Metastatic Melanoma
- (2013) Cristiana Lo Nigro et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MALAT1 — a paradigm for long noncoding RNA function in cancer
- (2013) Tony Gutschner et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Sensitive detection of melanoma metastasis using circulating microRNA expression profiles
- (2013) Rie Shiiyama et al. MELANOMA RESEARCH
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma
- (2013) Paige E. Bennett et al. PHYSIOLOGICAL GENOMICS
- BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene
- (2013) Srinivas V. Saladi et al. Pigment Cell & Melanoma Research
- PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma
- (2013) Yan Ye et al. Nature Communications
- PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
- (2013) Teruyuki Sato et al. Scientific Reports
- Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes
- (2013) Y. Saunthararajah Hematology-American Society of Hematology Education Program
- Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
- (2012) Y Xu et al. BRITISH JOURNAL OF CANCER
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells
- (2012) Peng Hou et al. CELL CYCLE
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
- (2012) Diana Guzman-Villanueva et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
- (2012) Luca Sigalotti et al. Journal of Translational Medicine
- In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA
- (2012) Jason A Hanna et al. LABORATORY INVESTIGATION
- JARID1B expression in human melanoma and benign melanocytic skin lesions
- (2012) Łukasz Kuźbicki et al. MELANOMA RESEARCH
- Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
- (2011) A. Heinemann et al. CANCER RESEARCH
- The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion
- (2011) D. Khaitan et al. CANCER RESEARCH
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
- (2011) Hisashi Kanemaru et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy
- (2011) M Gupta et al. LEUKEMIA
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
- (2011) Craig J. Ceol et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
- (2011) Luca A. Petruccelli et al. PLoS One
- The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?
- (2011) Moriah H. Nissan et al. Current Oncology Reports
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells
- (2010) Tzu-Yen Fu et al. EXPERIMENTAL CELL RESEARCH
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Silencing and re-expression of retinoic acid receptor beta2 in human melanoma
- (2010) Jun Fan et al. Pigment Cell & Melanoma Research
- Epidemiology of invasive cutaneous melanoma
- (2009) R. M. MacKie et al. ANNALS OF ONCOLOGY
- Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial
- (2009) A. I. Daud et al. CLINICAL CANCER RESEARCH
- MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth
- (2008) Julia Schultz et al. CELL RESEARCH
- Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
- (2008) Daniel E. Freedberg et al. JNCI-Journal of the National Cancer Institute
- The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to Transcription
- (2008) Gary LeRoy et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now